Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      St Jude cardiac implants prone to cyber attacks: Experts

      St Jude cardiac implants prone to cyber attacks: Experts

      savita thakur thakur25 Oct 2016 11:34 AM IST
      Short selling firm Muddy Waters said in a legal filing that outside experts it hired validated its claims that St. Jude Medical Inc cardiac implants...
      Fortis group gets CCI green light for internal reorganisation

      Fortis group gets CCI green light for internal reorganisation

      savita thakur thakur25 Oct 2016 11:25 AM IST
      New Delhi : The Competition Commission of India (CCI) has given its green light to the multi-layered reorganisation involving Fortis group...
      GGK Technologies launches HMIS software CurisHealth

      GGK Technologies launches HMIS software CurisHealth

      savita thakur thakur25 Oct 2016 11:17 AM IST
      Chennai : Sangita Reddy, Joint Managing Director Apollo Hospitals Enterprises Limited, unveiled GGK Technologies' advanced software product for end to...
      FDA approves Keytruda -Merck lung cancer drug as first line treatment

      FDA approves Keytruda -Merck lung cancer drug as first line treatment

      savita thakur thakur25 Oct 2016 9:48 AM IST
      Merck & Co Inc said the U.S. Food and Drug Administration has approved its immunotherapy Keytruda for use in certain previously untreated lung...
      Merck Announces Pivotal Phase 3 Study of Letermovir

      Merck Announces Pivotal Phase 3 Study of Letermovir

      savita thakur thakur24 Oct 2016 12:50 PM IST
      Kenilworth : Merck & Co., Inc., known as MSD outside the United States and Canada, announced that the pivotal Phase 3 clinical study of...
      Delay in patents can slow down improvement in medicine: Experts

      Delay in patents can slow down improvement in medicine: Experts

      savita thakur thakur24 Oct 2016 12:49 PM IST
      Mumbai : Delay in the patents for various innovations can slow down the improvement in the field of medicine, said health experts here.According to...
      Hester Biosciences to invest Rs 30 cr in new unit

      Hester Biosciences to invest Rs 30 cr in new unit

      savita thakur thakur24 Oct 2016 12:48 PM IST
      New Delhi : Animal health firm Hester Biosciences plans to invest nearly Rs 30 crore to set up a large unit for products."Our next goal is to invest...
      Roche bets on new cancer drugs to offset patent expiries

      Roche bets on new cancer drugs to offset patent expiries

      savita thakur thakur24 Oct 2016 9:48 AM IST
      Zurich : Roche said strong sales of new medicines like cancer immunotherapy drug Tecentriq would help to sustain the company's growth as patents on...
      Malaysian facility to be commercialised in H2 FY17: Biocon

      Malaysian facility to be commercialised in H2 FY17: Biocon

      savita thakur thakur23 Oct 2016 11:53 AM IST
      New Delhi : Biotechnology major Biocon said its manufacturing facility in Malaysia will be commercialised in the second half of the current financial...
      Mercks Keytruda succeeds in key bladder cancer trial

      Mercks Keytruda succeeds in key bladder cancer trial

      savita thakur thakur23 Oct 2016 11:51 AM IST
      Merck & Co Inc said its immunotherapy, Keytruda, helped previously treated patients with advanced bladder cancer live longer in a late-stage...
      Telangana to develop Medical devices park

      Telangana to develop Medical devices park

      savita thakur thakur23 Oct 2016 11:51 AM IST
      Hyderabad : Telangana Minister for Information Technology, Industries and Commerce and NRI Affairs, K T Rama Rao said they were developing a Medical...
      Sun Pharma completes Rs 675-crore share buyback

      Sun Pharma completes Rs 675-crore share buyback

      savita thakur thakur23 Oct 2016 11:46 AM IST
      New Delhi : Sun Pharma said it has completed buyback of shares worth Rs 675 crore to return surplus funds to its shareholders."The company on October...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok